EUVIMEDEUVIMED entdecken
Klinische StudieStudienprotokollOpen Access · CC BY-NC-ND 4.0

LiveWell: Pilot Feasibility Trial of an Adapted Dialectical Behavioral Therapy Skills Training Protocol in Patients With Metastatic Non‐Small Cell Lung Cancer

Kelly A Hyland iD, Andrada D Neacsiu iD, Hannah M Fisher, Colleen M Cowperthwait, Natalie Chou, Thomas E Stinchcombe, Kevin C Oeffinger, Laura S Porter iD, Caroline S Dorfman, Francis J Keefe, Tamara J Somers

Psycho-Oncology · 2025

DOI: 10.1002/pon.70357 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Psycho-Oncology, 2025. Verfasst von Kelly A Hyland und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Behavior Therapy, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Psychological Distress. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

People living longer with metastatic non‐small cell lung cancer (mNSCLC) experience heightened psychological distress and decrements in quality of life. Therefore, we developed LiveWell, an 8‐session adapted dialectical behavioral therapy skills training (DBT‐ST) protocol delivered one‐on‐one via telehealth to reduce psychological distress.

Aim

To conduct a single‐arm pilot trial examining the feasibility and acceptability of LiveWell and explore change in outcome variables.

Methods

Patients receiving systemic therapy for mNSCLC with at least mild distress participated. Outcomes were feasibility (accrual N = 30 in 18 months, > 80% sessions attended, < 25% attrition) and acceptability (> 80% participant satisfaction). Distress (depression and anxiety symptoms; primary outcomes), intolerance of uncertainty, emotion regulation, illness acceptance, symptoms (e.g., fatigue, dyspnea, pain), skill use, and quality of life (secondary outcomes) were assessed at baseline, post‐intervention (primary endpoint), and 1‐month post‐intervention and examined with paired sample t ‐tests.

Results

Thirty participants ( M age = 63 years, 77% female) consented and completed the baseline assessment. LiveWell met feasibility (accrual N = 30 in 8 months, 93% sessions attended, 87% retention at post‐intervention) and acceptability (96% satisfaction) benchmarks. Participants demonstrated reductions in distress (depression d = 0.35, anxiety d = 0.22) from baseline to post‐treatment. Intolerance of uncertainty ( d = 0.71), emotion regulation ( d = 0.49), and illness acceptance ( d = 0.45) improved. Fatigue and pain remained stable or improved ( d 's 0.07–0.38). Skill use increased ( d = 0.65) and quality of life improved ( d = 0.21). Improvements were maintained or enhanced at 1‐month follow‐up.

Conclusions

LiveWell was feasible and acceptable, and participants demonstrated promising improvement in primary and secondary outcomes. Findings support a larger randomized efficacy trial.

Trial registration

ClinicalTrials.gov Identifier: NCT04973436

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Behavior TherapyCarcinoma, Non-Small-Cell LungLung NeoplasmsPsychological DistressStress, PsychologicalAgedFemaleHumansMaleMiddle AgedAnxietyDepressionFeasibility StudiesPilot ProjectsQuality of LifeTelemedicine

Stichwörter der Autor:innen

dialectical behavioral therapyemotion regulationmetastatic non‐small cell lung cancerpsychosocial oncology

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA.
  • Division of Bio-Behavioral Medicine, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Psychiatry and Behavioral Sciences, Brain Stimulation Research Center, Duke University Medical Center, Durham, North Carolina, USA.
  • Duke Cancer Institute, Durham, North Carolina, USA.

ORCID-Profile: Kelly A Hyland, Andrada D Neacsiu, Laura S Porter

Förderung

  • NCI NIH HHS

Zitieren

APA

Hyland, K. A., Neacsiu, A. D., Fisher, H. M., Cowperthwait, C. M., Chou, N., Stinchcombe, T. E., Oeffinger, K. C., Porter, L. S., Dorfman, C. S., Keefe, F. J., & Somers, T. J. (2025). LiveWell: Pilot Feasibility Trial of an Adapted Dialectical Behavioral Therapy Skills Training Protocol in Patients With Metastatic Non‐Small Cell Lung Cancer. Psycho-Oncology. https://doi.org/10.1002/pon.70357

Vancouver

Hyland KA, Neacsiu AD, Fisher HM, Cowperthwait CM, Chou N, Stinchcombe TE, et al. LiveWell: Pilot Feasibility Trial of an Adapted Dialectical Behavioral Therapy Skills Training Protocol in Patients With Metastatic Non‐Small Cell Lung Cancer. Psycho-Oncology. 2025. doi:10.1002/pon.70357

BibTeX
@article{Hyland2025,
  author = {Hyland, Kelly A and Neacsiu, Andrada D and Fisher, Hannah M and Cowperthwait, Colleen M and Chou, Natalie and Stinchcombe, Thomas E and Oeffinger, Kevin C and Porter, Laura S and Dorfman, Caroline S and Keefe, Francis J and Somers, Tamara J},
  title = {LiveWell: Pilot Feasibility Trial of an Adapted Dialectical Behavioral Therapy Skills Training Protocol in Patients With Metastatic Non‐Small Cell Lung Cancer},
  journal = {Psycho-Oncology},
  year = {2025},
  doi = {10.1002/pon.70357}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche